Implementation of pharmaceutical services in Brazilian primary health care: a cross-sectional study

被引:1
作者
Pereira, Nathalia Cano [1 ]
Luiza, Vera Lucia [1 ]
Campos, Monica Rodrigues [2 ]
Chaves, Luisa Arueira [3 ]
机构
[1] Fundacao Oswaldo Cruz, Natl Sch Publ Heath Sergio Arouca, Dept Med Policy & Pharmaceut Serv, Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz, Natl Sch Publ Heath Sergio Arouca, Social Sci Dept, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Campus Macae, Rio De Janeiro, Brazil
关键词
Implementation Fidelity; Implementation research; Pharmaceutical service; Primary health care; PREVENTION; FIDELITY; MANAGEMENT; MEDICINES; INTEGRITY; ACCESS;
D O I
10.1186/s12875-021-01516-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background In the Brazilian public health system, primary health care (PHC) is provided by the municipalities and is considered the entry level of the Unified Health System (SUS). Governmental pharmaceutical services (PharmSes) are part of the SUS, including PHC, and are the most significant way in which patients access medicine and services. Considering the diversity of the country, the municipalities have the autonomy to decide how PharmSes are implemented. Even though policies and procedures should be implemented as expected by policy makers and experts, municipality characteristics may interfere with implementation fidelity. Therefore, this study evaluated the degree to which the PharmSes in PHC were delivered as intended in Brazilian municipalities. Methods We analysed data from a secondary database originating from a cross-sectional nationwide study carried out by the Ministry of Health and the World Bank from 2013 to 2015. Data on 465 municipalities and the Federal District were collected from 4939 governmental PharmSes. A rating system comprising 43 indicators was developed and applied to the dataset to obtain the implementation degree (ID) of each PharmSe. Additionally, the IDs of the two PharmSes dimensions and the nine components were measured. Results Overall, the ID of the PharmSes in Brazilian PHC was evaluated as critical. The ID was critical in 81% of the municipalities (n = 369), incipient in 14% (n = 65) and unsatisfactory in 4.8% (n = 22). Regarding the PharmSes dimensions, the 'medicine management' (MM) ID was considered critical (Mean = 46%), while the 'care management' (CM) ID was incipient (Mean = 22%). In terms of the PharmSes components, the highest ID was achieved by 'forecasting' (58%). In contrast, 'continuing education and counselling' showed the lowest figure (ID = 11%) in the whole sample, followed by 'information and communication' and 'teamwork'. Conclusions The degree to which PharmSes were implemented was critical (ID< 50%). This analysis demonstrated that PharmSes were implemented with low fidelity, which may be related to the low availability of medicine in PHC. Although the care management component requires more attention, considering their incipient ID, all components must be reviewed. Municipalities must increase their investment in PharmSes implementation in order to maximize the benefits of these services and guarantee the essential right of access to medicine.
引用
收藏
页数:11
相关论文
共 64 条
[1]  
Alvares J, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051007139, 10.11606/s1518-8787.2017051007139]
[2]  
[Anonymous], 2007, INDIAN J POLITICAL S
[3]   Comments on "The organization of pharmaceutical services by 'health region' in Brazil's Unified Health System" [J].
Araujo, Suetonio Queiroz ;
Costa, Karen Sarmento ;
Luiza, Vera Lucia ;
Lavras, Carmen ;
Santana, Eucilene Alves ;
Leao Tavares, Noemia Urruth .
CIENCIA & SAUDE COLETIVA, 2017, 22 (04) :1181-1191
[4]   The role of therapist adherence, therapist competence, and alliance in predicting outcome of individual drug counseling: Results from the National Institute Drug Abuse Collaborative Cocaine Treatment Study [J].
Barber, JP ;
Gallop, R ;
Crits-Christoph, P ;
Frank, A ;
Thase, ME ;
Weiss, RD ;
Gibbons, MBC .
PSYCHOTHERAPY RESEARCH, 2006, 16 (02) :229-240
[5]  
Barreto Maria Nelly Sobreira de Carvalho, 2015, Rev. bras. epidemiol., V18, P413, DOI 10.1590/1980-5497201500020010
[6]  
Barros DSL, 2019, TRABALHO EDUC SAUDE, P18
[7]  
Bertoldi AD, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006119, 10.1590/s1518-8787.2016050006119]
[8]  
Bigdeli M., 2014, Medicines in health systems: advancing access, affordability and appropriate use
[10]  
Brasil. Ministerio da Saude, 2014, CAP PAR IMPL SERV CL, P308